DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas

Not Applicable

Completed

Conditions: Chordoma

Interventions: Procedure: Fluoromisonidazole-PET/CT

First Posted Date: 2008-07-11

Last Posted Date: 2017-02-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT00713037

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)

Phase 3

Terminated

Conditions: Huntington's Disease

Interventions: Drug: Creatine Monohydrate
Drug: Placebo

First Posted Date: 2008-07-10

Last Posted Date: 2016-03-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 553

Registration Number: NCT00712426

Locations: 🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸
Albany Medical College, Albany, New York, United States
🇺🇸
University of Tennessee Health Science Center, Memphis, Tennessee, United States

and more 44 locations

Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD

Completed

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)

First Posted Date: 2008-07-09

Last Posted Date: 2010-06-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT00711724

Locations: 🇺🇸
Massachusetts General Hospital, Cambridge, Massachusetts, United States

A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol

Phase 4

Completed

Conditions: Posttraumatic Stress Disorder

Interventions: Drug: Propranolol
Drug: Placebo

First Posted Date: 2008-07-03

Last Posted Date: 2017-04-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 23

Registration Number: NCT00709735

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
VA Medical Center, Manchester, New Hampshire, United States

A Maintenance Program for the Be Fit Employee Wellness Program

Not Applicable

Completed

Conditions: Obesity
Overweight

Interventions: Behavioral: Internet-based maintenance program

First Posted Date: 2008-07-01

Last Posted Date: 2017-05-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 330

Registration Number: NCT00707577

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study

Phase 1

Terminated

Conditions: Healthy

Interventions: Drug: Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System

First Posted Date: 2008-06-30

Last Posted Date: 2014-06-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 6

Registration Number: NCT00706784

Locations: 🇺🇸
Clinical Unit for Research Trials In Skin (CURTIS), Boston, Massachusetts, United States

Brief CBT for Anxiety and Advanced Cancer

Phase 2

Completed

Conditions: Depression
Anxiety
Unspecified Adult Solid Tumor, Protocol Specific
Cancer
Cognitive Behavioral Therapy

Interventions: Behavioral: Brief Cognitive Behavioral Therapy

First Posted Date: 2008-06-27

Last Posted Date: 2014-06-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 49

Registration Number: NCT00706290

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

Phase 1

Completed

Conditions: HIV Infections

Interventions: Drug: Highly Active Antiretroviral Therapy (HAART)
Other: No treatment

First Posted Date: 2008-06-27

Last Posted Date: 2017-08-31

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 25

Registration Number: NCT00705926

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Intra-Operative Dural Brachytherapy With Yttrium-90 Plaque Applicators

Not Applicable

Terminated

Conditions: Spinal Neoplasms

Interventions: Device: Yttrium-90 Plaque Applicator

First Posted Date: 2008-06-27

Last Posted Date: 2016-10-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5

Registration Number: NCT00706485

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)

Phase 2

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: BCI-024 (Buspirone)
Drug: Matching placebo

First Posted Date: 2008-06-25

Last Posted Date: 2014-06-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 142

Registration Number: NCT00705003

Locations: 🇺🇸
FutureSearch Trials of Dallas, L.P., Dallas, Texas, United States
🇺🇸
CRI Worldwide, Philadelphia, Pennsylvania, United States
🇺🇸
Synergy Research Centers, San Diego, California, United States

and more 6 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy